Sector: Healthcare > Industry: Veterinary Drugs
Aratana Therapeutics, Inc. is a development-stage biopharmaceutical company. As of March 20, 2013, the Company has three licensed compounds in development for six product approvals in cats and dogs in each of the United States and Europe. The Company is developing several compounds for the pet health market, including a non-COXIB analgesic for treating pain, an appetite-stimulating molecule for inappetence, and licensed non-opioid local anesthetic for treating post-operative pain. The company is actively identifying additional programs to in-license from human health companies in order to expand its development pipeline of animal medicines.
Address
1901 Olathe Blvd
KANSAS CITY, KS 66103
United States
KANSAS CITY, KS 66103
United States
Website links
http://www.aratana.comKey stats and ratios
| Q1 (Mar '13) | 2012 | |
| Net profit margin | - | - |
| Operating margin | - | - |
| EBITD margin | - | - |
| Return on average assets | - | -68.86% |
| Return on average equity | - | - |
| Employees | 16 |
No comments:
Post a Comment